Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 1/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL29130111 | 0.98 | CDC25A (0.34) | CDC25ACTDSP1LMNATSHR | |
| Water SCHEMBL4076896 | 0.98 | CDC25A (0.34) | CDC25ACTDSP1LMNATSHR | |
| SCHEMBL28359649 | 0.91 | CDC25A (0.40) | CDC25ACTDSP1TSHR | |
| SCHEMBL4058936 | 0.91 | CDC25A (0.40) | CDC25ACTDSP1TSHR | |
| SCHEMBL10034058 | 0.91 | CDC25A (0.40) | CDC25ACTDSP1TSHR | |
| SCHEMBL4452005 | 0.91 | CDC25A (0.40) | CDC25ACTDSP1TSHR | |
| SCHEMBL4067219 | 0.91 | CDC25A (0.40) | CDC25ACTDSP1TSHR | |
| SCHEMBL1962073 | 0.91 | CDC25A (0.37) | CDC25ACTDSP1LMNATSHR | |
| SCHEMBL9936322 | 0.91 | HPGD (0.34) | CDC25ACTDSP1 | |
| SCHEMBL18526268 | 0.91 | CTDSP1 (0.33) | CDC25ACTDSP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240359168-A1 | Mesoporous Catalyst Compounds and Uses Thereof | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2024-10-31 | — | — | US | disclosed |
| US-12064752-B2 | Mesoporous catalyst compounds and uses thereof | ExxonMobil Technology and Engineering Company (US) | 2024-08-20 | — | — | US | disclosed |
| US-20220143586-A1 | Mesoporous Catalyst Compounds and Uses Thereof | EXXONMOBIL RES & ENG CO (US) | 2022-05-12 | — | — | US | disclosed |
| EP-3941621-A1 | MESOPOROUS CATALYST COMPOUNDS AND USES THEREOF | ExxonMobil Research and Engineering Company (US) | 2022-01-26 | — | — | EP | disclosed |
| WO-2020190367-A1 | MESOPOROUS CATALYST COMPOUNDS AND USES THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2020-09-24 | — | — | WO | disclosed |
| WO-2020031836-A1 | POLYMERIZABLE IONIC LIQUID, POLYMER, CURABLE COMPOSITION, ELECTROCHEMICAL ELEMENT MATERIAL, AND ANTISTATIC MATERIAL | セントラル硝子株式会社 | 2020-02-13 | — | — | WO | disclosed |
| EP-2920113-B1 | SYNTHESIS OF MCM-68 MOLECULAR SIEVE | EXXONMOBIL RES & ENG CO (US) | 2018-01-03 | — | — | EP | disclosed |
| EP-2958181-B1 | NON-AQUEOUS ELECTROLYTIC SOLUTION AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEM CORP (JP) | 2017-06-14 | — | — | EP | disclosed |
| US-9653754-B2 | Nonaqueous electrolytes and nonaqueous-electrolyte secondary batteries employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-05-16 | — | — | US | disclosed |
| US-9620814-B2 | — | — | 2017-04-11 | — | — | US | disclosed |
| US-20090103241-A1 | Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-04-23 | — | — | US | disclosed |
| WO-2009040107-A2 | METHOD FOR THE PRODUCTION OF METAL-CONTAINING NANOPARTICLES | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-04-02 | — | — | WO | disclosed |
| WO-2009024312-A2 | METHOD FOR THE PRODUCTION AND STABILIZATION OF FUNCTIONAL METAL NANOPARTICLES IN IONIC LIQUIDS | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-02-26 | — | — | WO | disclosed |
| US-20080094777-A1 | Electric double layer capacitor | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-04-24 | — | — | US | disclosed |
| EP-1905740-A1 | ELECTRIC DOUBLE LAYER CAPACITOR | Sumitomo Chemical Company, Limited (JP) | 2008-04-02 | — | — | EP | disclosed |
| EP-1876611-A1 | ELECTRIC DOUBLE LAYER CAPACITOR | Sumitomo Chemical Company, Limited (JP) | 2008-01-09 | — | — | EP | disclosed |
| EP-0619300-B1 | Process for the preparation of halogenmethylbenzoyl cyanides and halogenmethyl benzoylcyanides | BASF AG (DE) | 1996-12-27 | — | — | EP | disclosed |
| US-5510528-A | Preparation of halomethylbenzoly cyanides and novel halomethylbenzoyl cyanides | BASF AKTIENGESELLSCHAFT (DE) | 1996-04-23 | — | — | US | disclosed |
| US-5446199-A | Preparation of halomethylbenzoyl cyanides and novel halomethylbenzoyl cyanides | BASF AKTIENGESELLSCHAFT (DE) | 1995-08-29 | — | — | US | disclosed |
| EP-0619300-A2 | Process for the preparation of halogenmethylbenzoyl cyanides and halogenmethyl benzoylcyanides | BASF Aktiengesellschaft (DE) | 1994-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090103241-A1 | Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 | CBR1, CYP24A1, CALU | CDC25A 1582/4885CTDSP1 1634/4885LMNA 3983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.